ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit +11 more
wiley +1 more source
The impact of chest compression rates on quality of chest compressions : a manikin study [PDF]
Purpose Chest compressions are often performed at a variable rate during cardiopulmonary resuscitation (CPR). The effect of compression rate on other chest compression quality variables (compression depth, duty-cycle, leaning, performance decay over ...
Field, Richard A. +17 more
core +1 more source
Development of Knitted Compression Covers for Amputated Limbs
Compression therapy can be successfully applied to the treatment of amputated limbs. Compression is known to speed healing and reduce the appearance of complex scars. This is particularly relevant as the number of amputations increases, especially during
Daiva Mikucioniene +5 more
doaj +1 more source
Physiotherapeutic procedure on the example of compression therapy in treatment of venous diseases
The aim of this study is an attempt to systematise the knowledge about physiotherapy in the process of treatment of vascular diseases, with particular focus on compression therapy.
Mateusz Curyło +4 more
doaj +1 more source
Onasemnogene Abeparvovec in Patients With SMA: Interim Results of the RESTORE Registry in Japan
ABSTRACT Objective There are limited real‐world data regarding the safety and effectiveness of onasemnogene abeparvovec (OA; Zolgensma) infusion, a one‐time gene replacement therapy, for Japanese patients with spinal muscular atrophy (SMA). We aimed to improve understanding of the real‐world outcomes for OA in Japan.
Kayoko Saito +8 more
wiley +1 more source
Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy
ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini +9 more
wiley +1 more source
Kikuhime Device in the Management of Venous Leg Ulcers
Marian Karafa, Anna Karafova Faculty of Physical Education, Gdansk University of Physical Education and Sport, Gdansk, PolandCorrespondence: Marian KarafaGdansk University of Physical Education and Sport, Department of Physiotherapy, Kazimierza Gó ...
Karafa M, Karafova A
doaj
A Case Report on Theruptor Novo: An Antimicrobial Dressing in the Management of Venous Leg Ulcer [PDF]
Venous Leg Ulcer (VLU) is defined as any break in the skin that has either been present for longer than six weeks or occurs in a person with a history of VLU.
Subhash M Kale
doaj +1 more source
Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa +3 more
wiley +1 more source
Design of an Intelligent Compression Stocking for Reducing Ulcer Healing Time
Venous leg ulcers remain a problem in the United States, costing the health care industry nearly $1 billion annually. A major portion of this spending is incurred as a result of prolonged healing time. Compression therapy is known to promote recovery.
Hegarty, Meghan Sarah
core

